Brandon Cam4

The FDA Thursday granted accelerated approval for tucatinib when given with trastuzumab to deal with adults with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer that progresses following therapy with…

Continuer la lectureBrandon Cam4